BP000617-PKA-229: Recombinant Human Hexokinase-3
Source: E.coli-derived.
Purity>95.0% by RP-HPLC and SDS-PAGE.BP000615-PKA-226: Recombinant Human Hexokinase-1
Source: E. coli-derived.
Specific activity is 7-8 units/ml obtained by measuring the increase of NADPH in absorbance at 340 nm resulting from the reduction of NADP. In the coupled mode, one unit will produce 1.0 umole of NADPH per minute as glucose is phosphorylated by ATP at pH 7.4 at 30C.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000629-ENZ-038: Recombinant Human Haloacid Dehalogenase-like Hydrolase Domain Containing 2 (HDHD2) Enzyme
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000709-ENZ-424: Recombinant Human Histone Deacetylase 1
Source: Hi-5 Baculovirus-derived.
Purity > 90%, by RP-HPLC and SDS-PAGE.BP000421-HCV-224: Recombinant HCV NS5 Genotype-6
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-234: Recombinant HCV NS5 Genotype-6a
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-221: Recombinant HCV NS5 Genotype-3
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000421-HCV-233: Recombinant HCV NS5 Genotype-3b
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000421-HCV-232: Recombinant HCV NS5 Genotype-3a
Source: E. coli-derived.
Purity >95%, as determined by 10% PAGE (coomassie staining).
Specificty:Immunoreactive with sera of HCV-infected individuals.
Applications: ELISA, WB.BP000421-HCV-229: Recombinant HCV NS5 Genotype-2
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.